Brain Imaging Finds CB1 Receptor Levels Linked to Emotional Numbing in PTSD, Not Overall Diagnosis
A PET study found no overall difference in CB1 receptor availability between PTSD patients and controls, but emotional numbing symptoms were significantly linked to CB1 receptor levels, suggesting a nuanced endocannabinoid role.
Quick Facts
What This Study Found
Among 62 participants (19 with current PTSD, 27 trauma-exposed controls, 16 healthy controls), no differences in CB1 receptor availability were found between groups in whole brain or regions of interest. However, emotional numbing symptoms of PTSD were significantly associated with CB1R availability, suggesting the endocannabinoid system relates to specific symptom dimensions rather than the diagnosis overall.
Key Numbers
62 participants; 19 with PTSD; no group differences in CB1R availability; significant association between CB1R and emotional numbing symptoms specifically.
How They Did This
PET imaging study using [11C]OMAR, a CB1R-specific radiotracer, in 62 individuals. 46 trauma-exposed (19 with current PTSD) and 16 healthy controls. Analysis of whole-brain and region-of-interest CB1R availability correlated with PTSD symptom clusters.
Why This Research Matters
This challenges a previous study that found elevated CB1R in PTSD and refines our understanding. The endocannabinoid system may not drive PTSD broadly but could specifically contribute to emotional numbing, which is one of the most treatment-resistant symptom clusters.
The Bigger Picture
The finding that CB1R relates to emotional numbing specifically could explain why some PTSD patients report cannabis helps "feel again" while others find it worsens dissociation. It supports developing cannabinoid-targeted treatments for specific PTSD symptom clusters rather than PTSD as a whole.
What This Study Doesn't Tell Us
Modest sample size (19 PTSD patients). Cross-sectional design. Single PET tracer. Cannabis use history in participants could affect CB1R availability. Cannot determine directionality of the CB1R-numbing association.
Questions This Raises
- ?Would cannabinoid therapies specifically targeting emotional numbing be more effective than broad PTSD treatments?
- ?Do CB1R levels change with PTSD treatment or symptom improvement?
Trust & Context
- Key Stat:
- CB1R linked to emotional numbing, not PTSD diagnosis overall
- Evidence Grade:
- PET imaging with specific radiotracer provides direct receptor measurement, but modest sample size and cross-sectional design limit conclusions.
- Study Age:
- 2025 publication
- Original Title:
- Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study.
- Published In:
- Translational psychiatry, 15(1), 310 (2025)
- Authors:
- Korem, Nachshon(2), Bassir Nia, Anahita(3), Hillmer, Ansel T(2), D'Souza, Deepak, Nabulsi, Nabeel, Ropchan, Jim, Huang, Yiyun, Cosgrove, Kelly, Levy, Ifat, Pietrzak, Robert H, Harpaz-Rotem, Ilan
- Database ID:
- RTHC-06853
Evidence Hierarchy
Frequently Asked Questions
Is the endocannabinoid system involved in PTSD?
This PET study found no overall difference in CB1 receptor levels between PTSD patients and controls. However, CB1R was specifically linked to emotional numbing symptoms, suggesting the endocannabinoid system plays a nuanced role in specific PTSD symptom dimensions.
Can cannabis help with PTSD numbing?
This study found a biological link between CB1 receptor levels and emotional numbing in PTSD. While this provides a rationale for cannabinoid-targeted treatments, clinical trials are needed to determine whether modulating CB1R actually improves numbing symptoms.
Read More on RethinkTHC
- anxiety-leaving-house-weed-withdrawal-agoraphobia
- anxiety-response-technique-weed-withdrawal
- anxiety-toolkit-weed-withdrawal
- anxiety-worse-after-quitting-weed
- breathing-exercises-weed-withdrawal-anxiety
- cannabis-induced-anxiety
- does-weed-help-anxiety
- grounding-techniques-weed-withdrawal
- health-anxiety-weed-withdrawal
- manage-anxiety-without-weed
- quitting-weed-anxiety-disorder
- quitting-weed-anxiety-medication-ssri
- self-medicating-anxiety-with-weed
- therapy-quitting-weed-anxiety
- weed-and-anxiety
- weed-biphasic-effect-anxiety
- weed-generalized-anxiety-disorder
- weed-panic-attacks
- weed-paranoia
- weed-social-anxiety
- weed-tolerance-anxiety-stopped-working
- weed-withdrawal-anxiety
- weed-withdrawal-panic-attacks-night
- weed-withdrawal-work-anxiety
- withdrawal-anxiety-vs-real-anxiety
Cite This Study
https://rethinkthc.com/research/RTHC-06853APA
Korem, Nachshon; Bassir Nia, Anahita; Hillmer, Ansel T; D'Souza, Deepak; Nabulsi, Nabeel; Ropchan, Jim; Huang, Yiyun; Cosgrove, Kelly; Levy, Ifat; Pietrzak, Robert H; Harpaz-Rotem, Ilan. (2025). Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study.. Translational psychiatry, 15(1), 310. https://doi.org/10.1038/s41398-025-03519-9
MLA
Korem, Nachshon, et al. "Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study.." Translational psychiatry, 2025. https://doi.org/10.1038/s41398-025-03519-9
RethinkTHC
RethinkTHC Research Database. "Cannabinoid 1 receptor availability in posttraumatic stress ..." RTHC-06853. Retrieved from https://rethinkthc.com/research/korem-2025-cannabinoid-1-receptor-availability
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.